FDA Orange Book
Generic for Lumigan
Lumigan contains bimatoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Lumigan is bimatoprost. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AT.
Run it in Rivvi
Map Lumigan and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Lumigan products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution/drops, ophthalmic | 0.01% | Marketed (Rx) | AB | 2 | AB |
| solution/drops, ophthalmic | 0.03% | Discontinued | None | 7 | AT |
NDA 022184, 021275, held by ABBVIE INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic bimatoprost
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| SANDOZ INC | 202565 | AT (A-rated, therapeutically equivalent) | May 5, 2015 | 0.03% |
| APOTEX INC | 090449 | AT (A-rated, therapeutically equivalent) | July 20, 2015 | 0.03% |
| GLAND PHARMA LTD | 210126 | AT (A-rated, therapeutically equivalent) | March 22, 2019 | 0.03% |
| ALEMBIC PHARMACEUTICALS LTD | 210263 | AT (A-rated, therapeutically equivalent) | April 12, 2019 | 0.03% |
| SOMERSET THERAPEUTICS LLC | 207601 | AT (A-rated, therapeutically equivalent) | June 19, 2019 | 0.03% |
| MICRO LABS LTD | 202505 | AT (A-rated, therapeutically equivalent) | September 8, 2020 | 0.03% |
| EUGIA PHARMA SPECIALITIES LTD | 205537 | AT (A-rated, therapeutically equivalent) | October 6, 2022 | 0.03% |
| MANKIND PHARMA LTD | 218196 | AB (A-rated, therapeutically equivalent) | March 17, 2025 | 0.01% |
| AMNEAL EU LTD | 217289 | AB (A-rated, therapeutically equivalent) | September 22, 2025 | 0.01% |
Lumigan patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7851504 | June 13, 2027 | Drug substance, Drug product | None | 022184 |
Lumigan NDC codes
Questions
Is there a generic for Lumigan?
Yes. The generic name for Lumigan is bimatoprost. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AT.
What is the generic name for Lumigan?
The active ingredient in Lumigan is bimatoprost, per the FDA Orange Book.
When does the Lumigan patent expire?
The last patent listed for Lumigan in the Orange Book expires June 13, 2027. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Lumigan and Bimatoprost
- What is Lumigan used for?FDA label uses
- Is Lumigan a controlled substance?Federal schedule
- What is Bimatoprost used for?FDA label uses
- Is Bimatoprost a controlled substance?Federal schedule
- Generic for ZolymbusFDA Orange Book
- Generic for DurystaFDA Orange Book
- Generic for LatisseFDA Orange Book
- Prostaglandin Analogs listFDA drug class
- Lumigan Medicare Part D coverageBy plan and state
- NDC 0023-3205Lumigan NDC record